Revolax Deep Regulatory Status: A Guide for Aesthetic Professionals

Revolax Deep is a hyaluronic acid (HA) dermal filler developed by Across Biotech, a South Korean manufacturer. As a core product in many aesthetic clinics, its intended use is for volume restoration and contouring. Knowing the product's origin is the first step in understanding its primary regulatory oversight and subsequent market access pathways.

Professionals seeking to stock a diverse range of HA fillers may also consider options such as LEXYAL or exploring our full Hyaluronic acid dermal filler catalog for comprehensive clinic supplies.

For products originating in South Korea, the Korea Food & Drug Administration (KFDA) approval is a primary benchmark of quality and safety within its domestic market. Revolax Deep holds KFDA certification, affirming its compliance with national standards.

Market access beyond South Korea relies on additional certifications:

• CE Mark: The CE (Conformité Européenne) Mark is critical for products distributed within the European Economic Area (EEA) and the UK. It signifies that the product meets the health, safety, and environmental protection standards of the EU. Revolax Deep possesses CE certification, enabling its distribution in these regions.
• FDA Approval: [VERIFY: Revolax Deep FDA approval status for direct US market sales]. that CE marking does not equate to FDA approval for the United States market.
• GMP/ISO Compliance: Across Biotech manufacturing facilities operate under Good Manufacturing Practices (GMP) and typically adhere to international quality management standards such such as ISO 13485. [VERIFY: Specific ISO 13485 certification and GMP compliance for Across Biotech and Revolax Deep manufacturing] These standards ensure consistent product quality and safety during production.

The CE Mark facilitates Revolax Deep's legal distribution across the European Union and the United Kingdom. For other global markets, regulatory requirements vary.

• GCC (Gulf Cooperation Council) and LATAM (Latin America): Market entry in these regions often requires product registration with local health authorities, which may involve submitting CE Mark documentation, KFDA approvals, and local clinical data. Import and distribution must comply with each country's specific pharmaceutical and medical device regulations.
• APAC (Asia-Pacific): Beyond South Korea, countries like Australia, New Zealand, Singapore, and others have their own health product regulatory bodies. Approvals can range from direct recognition of CE/KFDA to requiring additional local data and registration processes.

Clinic owners are responsible for verifying local import and usage regulations for Revolax Deep within their specific jurisdiction.

Parallel importing involves sourcing products from a market where they are legitimately sold and importing them into another market, often outside the manufacturer's official distribution channels. While not always illegal, parallel imports can present risks for aesthetic professionals:

• Traceability: It becomes more challenging to verify the product's origin, storage conditions, and authenticity. This directly impacts patient safety and professional liability.
• Cold Chain Integrity: Products like dermal fillers require specific storage conditions. Parallel imports may bypass strict cold chain protocols, compromising product stability.
• Legal Recourse: In cases of adverse events, seeking recourse may be complex without a clear, authorized supply chain. Professionals should prioritize authorized distributors who provide full traceability and documentation, similar to the guidelines for sourcing products like Dermalax Deep Plus: A Professional Wholesale Sourcing Guide.

For every shipment of Revolax Deep, clinics should demand comprehensive documentation from their suppliers. This includes:

• Batch Numbers and Expiry Dates: Clear labeling and records are non-negotiable.
• Certificate of Analysis (CoA): This document verifies that each batch meets quality specifications.
• Certificate of Authenticity (CoA): While not universally provided by all manufacturers, reputable suppliers should be able to guarantee product legitimacy. For further insight on verifying product authenticity, refer to resources like Verifying Genuine Kiara Reju for Professional Aesthetic Prac.
• Customs Declarations and Import Licenses: Proof of legal import and compliance with local regulations.

Diligent supplier verification is essential to mitigate risks associated with counterfeit or unethically sourced products.

When integrating Revolax Deep into a clinic's inventory, strategic wholesale sourcing is key. Factors beyond regulatory status include pricing structures, volume discounts, and consistent supply. For example, the illustrative wholesale price for Revolax Deep is $75.2 per unit, with volume tiers offering additional discounts: 11 units → 4%, 21 units → 5%, 31 units → 6%, and 51+ units → 8%.

Understanding these tiers allows clinics to optimize procurement costs. Reliable suppliers ensure not only competitive pricing but also the consistent availability of genuine, properly handled products like Elasty Plus 1CC and other essential injectables.